Introduction: The challenges of pediatric asthma

Journal of Respiratory Diseases - For Pediatricians

Volumn 5, Issue 2, 2003, Pages 61-66

  Haver, Kenan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bronchoscopic evidence of airway inflammation; Circumstances surrounding asthma deaths; Goals for well controlled asthma; The risk of asthma mortality

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; IPRATROPIUM BROMIDE; LEUKOTRIENE; NEDOCROMIL; SALBUTAMOL; THEOPHYLLINE;

AIRWAY; ASTHMA; BREATHING MUSCLE; BRONCHOSCOPY; CAUSE OF DEATH; CHILD DEATH; CHRONIC INFLAMMATION; COST OF ILLNESS; DISEASE CONTROL; DRUG APPROVAL; DRUG TARGETING; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; LUNG FUNCTION; MORTALITY; PATHOPHYSIOLOGY; PEDIATRICS; REVIEW; RISK FACTOR; SPIROMETRY; TREATMENT OUTCOME;

EID: 0037353278     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Centers for Disease Control and Prevention. Surveillance for asthma - United States, 1960-1995. MMWR. 1998;47(SS-1):1-28.
2. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol. 2090;106:493-499.
3. National Asthma Education and Prevention Program. Clinical Practice Guidelines: Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: National Institutes of Health/National Heart, Lung, and Blood Institute; 1997. NIH publication 97-4051A.
4. Barnes P. Asthma Therapy. Oxford, England: Connect Pharma, Ltd; 1995.
5. NHLBI/WHO Workshop Report. January 1995. Available at: http://sirio.stat.unipd.it/gina/book/DEFAULT.HTML. Accessed February 27, 2003.
6. Busse WW, Calhoun WF, Sedgwick JD. Mechanism of airway inflammation in asthma. Am Rev Respir Dis. 1993;147:S20-S24.
7. Price DB, Ben-Joseph RH, Zhang Q. Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.K. Respir Med. 2001;95:83-89.
8. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol. 2001;107:3-8.
9. Massachusetts Division of Health Care Finance and Policy, 1998. Available at: http://www.state.ma.us/dhcfp/. Accessed February 27, 2003.
10. Qureshi F, Pestian J, Davis P, Zaritsky A. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med. 1998;339:1030-1035.
11. National Asthma Education and Prevention Program. Guidelines for the Diagnosis and Management of Asthma - Update on Selected Topics 2002. Bethesda, Md: National Institutes of Health/National Heart, Lung, and Blood Institute; June 2002. NIH publication 02-5075.
12. Finkelstein JA, Lozano P, Shulruff R, et al. Self-reported physician practices for children with asthma: are national guidelines followed? Pediatrics. 2000;106:886-896.
13. American Lung Association asthma survey, 2001.
14. Asthma in America Survey. SRBI. December 1998. Available at: http://www.asthmainamerica.com/. Accessed February 27, 2003.
15. Goodman DC, Lozano P, Stukel TA, et al. Has asthma medication use in children become more frequent, more appropriate, or both? Pediatrics. 1999;104:187-194.
16. Donahue JF, Weiss ST, Livingston JM, et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 1997;277:887-891.
17. Gerdtham UG, Hertzman P, Jonsson B, Boman G. Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden 1978 to 1991. Med Care. 1996;34:1188-1198.
18. Wennergren G, Kristjansson S, Strannegard IL. Decrease in hospitalization for treatment of childhood asthma with increased use of anti-inflammatory treatment, despite an increase in prevalence of asthma. J Allergy Clin Immunol. 1996;97:742-748.
19. Robertson CF, Rubinfeld AR, Bowes G. Pediatric asthma deaths in Victoria: the mild are at risk. Pediatr Pulmonol. 1992;13:95-100.
20. Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343:332-336.
21. Malfino NA. Near-fatal asthma. In: Hall JB, Corbridge T, Rodrigo G, Rodrigo C, eds. Acute Asthma: Assessment and Management. New York: McGraw-Hill; 2000:chap 3.
22. Nannini LJ Jr. Morbidity and mortality from acute asthma. In: Hall JB, Corbridge T, Rodrigo G, Rodrigo C, eds. Acute Asthma: Assessment and Management. New York: McGraw-Hill; 2000:chap 2.
23. Lara M, Rosenbaum S, Rachelefsky G, et al. Improving childhood asthma outcomes in the United States: a blueprint for policy action. Pediatrics. 2002;109:919-930.